OQS
ATNM icon

Occudo Quantitative Strategies’s Actinium Pharmaceuticals ATNM Stock Holding History

Occudo Quantitative Strategies’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31,662
Closed -$235K – 970
2023
Q2 		$235K Buy
+31,662
New +$269K 0.02% 808

Other funds holding ATNM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Occudo Quantitative Strategies's ATNM Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Actinium Pharmaceuticals (ATNM) in Q3 2023, closing a stake of 31,662 shares — an estimated $235K sold.

Occudo Quantitative Strategies first reported a position in ATNM in Q2 2023 and held it in 1 quarter. The position peaked at $235K in Q2 2023. 58 funds tracked by Wall St. Rank hold ATNM as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Actinium Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 31,662 Actinium Pharmaceuticals shares in Q3 2023, an estimated $235K.
  • Occudo Quantitative Strategies first reported a position in Actinium Pharmaceuticals in Q2 2023 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Actinium Pharmaceuticals position peaked at $235K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.